Beyond Biotech - the podcast from Labiotech cover image

Beyond Biotech podcast 53: Antibody-drug conjugates

Beyond Biotech - the podcast from Labiotech

00:00

The Future of Antibody-Drug Conjugates and Company Ambitions

This chapter explores the role of big companies in antibody-drug conjugates, discussing market dominance, recent deals, and potential therapeutic modalities. The speaker emphasizes the importance of having an ADC platform in oncology players and building a pipeline of novel ADCs.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app